Orby, Co.
Aldren Martins is the Chief Product Officer at Orby.co, a medical technology company focused on developing innovative systems for non-invasive neuromodulation and functional rehabilitation since September 2022. Aldren also serves as a member of the advisory board at FUNPEC and participated in a research project at the Federal University of Rio Grande do Norte from April 2022 to December 2023, aimed at creating an automated algorithm for classifying Alzheimer's Disease using MRI data. Previous experience includes an internship in Clinical Engineering at Hospital Universitário Onofre Lopes and a scientific initiation scholarship at the Federal University of Rio Grande do Norte, where Aldren contributed to projects involving magnetic bearings and PID controller simulations. Aldren holds a Bachelor's degree in Biomedical Engineering and an Interdisciplinary Bachelor's degree in Science and Technology from the same institution.
This person is not in any teams
This person is not in any offices
Orby, Co.
1 followers
The Orby, Co. is a medical technology company responsible for the development of a pioneering system for the non-invasive neuromodulation and automation of functional rehabilitation. His method significantly reduces the risks, costs, and complications associated with implantable procedures, as indicated in cases of stroke, spinal cord injury, Alzheimer's, Parkinson's, and trauma, among other musculoskeletal disorders. Orby offers healthcare institutions the perfect fusion of software, hardware, and control system. We orchestrate functional movement rehabilitation to create a streamlined workflow and automate neuromodulation processes. With a unique tool capable of filling out medical protocols, scheduling sessions with devices, viewing biofeedbacks, monitoring rehabilitation, and controlling neuromodulators to perform the functional movement. Furthermore, it is possible to obtain additional data that qualify the diagnosis, provide a predictive medical approach, indicate the progression of musculoskeletal disorders, and favor the productivity of care, evolution, and patient safety.